The relationship between the commensal microbiota levels and Crohn's disease activity
- PMID: 33102745
- PMCID: PMC7578322
- DOI: 10.1002/jgh3.12338
The relationship between the commensal microbiota levels and Crohn's disease activity
Abstract
Background and aim: Human gut microbiota play an important role in metabolism and host physiology. Perturbations of the gut microbial communities lead to the development of various diseases such as inflammatory bowel disease, celiac disease, allergic diseases, and metabolic diseases. Crohn's disease is a chronic inflammatory bowel disease characterized by periods of remission and relapse. Several studies suggest that intestinal inflammation arises due to an abnormal response of the intestinal immune system to the fecal microbiota. The goal of the study was to evaluate the relative amount of four bacterial groups in fecal samples of Crohn's disease patients and their relation to the inflammatory activity.
Methods: We studied stool samples of 105 individuals, 54 with Crohn's disease and 51 as a control group. The DNA extracted from the stool samples was subjected to real-time polymerase chain reaction (qPCR) for quantification of the Bacteroidetes phylum, class Bacilli, and Bifidobacteriaceae and Enterobacteriaceae families.
Results: We found a significant increase in Bacteroidetes in Crohn's disease samples when compared to the control group (14 650 and 2060 CFU/ng DNA, respectively) (P = 0.014). On the other hand, we observed a significant reduction in Bacilli and Bifidobacteriaceae (13 and 58 CFU/ng DNA, respectively) (P < 0.0001). In contrast, patients without any drug treatment presented an increase of Bacilli and Bifidobacteriaceae (102 521 and 6235 CFU/ng DNA, respectively) (P < 0.0001).
Conclusion: The commensal bacteria were decreased in fecal samples of participants with Crohn's disease when compared to the control group. There was no relation between the disease location and/or disease activity with the microbiota.
Keywords: Crohn's disease; bacilli; bacteroidetes; bifidobacteriaceae and enterobacteriaceae; gut microbiota.
© 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223. World J Gastroenterol. 2018. PMID: 30581271 Free PMC article.
-
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.J Crohns Colitis. 2016 Mar;10(3):296-305. doi: 10.1093/ecco-jcc/jjv209. Epub 2015 Nov 15. J Crohns Colitis. 2016. PMID: 26574491 Free PMC article.
-
Crohn's disease: a role of gut microbiota and Nod2 gene polymorphisms in disease pathogenesis.Acta Medica (Hradec Kralove). 2014;57(3):89-96. doi: 10.14712/18059694.2014.46. Acta Medica (Hradec Kralove). 2014. PMID: 25649363 Review.
-
Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.Immunol Rev. 2014 Jul;260(1):249-60. doi: 10.1111/imr.12193. Immunol Rev. 2014. PMID: 24942694 Review.
Cited by
-
A proposal for the reference intervals of the Italian microbiota "scaffold" in healthy adults.Sci Rep. 2022 Mar 10;12(1):3952. doi: 10.1038/s41598-022-08000-x. Sci Rep. 2022. PMID: 35273317 Free PMC article.
-
Analyzing the intestinal microbiome in inflammatory bowel disease: From RNA to multiomics.JGH Open. 2020 Oct 21;4(5):779-781. doi: 10.1002/jgh3.12374. eCollection 2020 Oct. JGH Open. 2020. PMID: 33102743 Free PMC article. No abstract available.
-
Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.Nutrients. 2023 Jul 29;15(15):3377. doi: 10.3390/nu15153377. Nutrients. 2023. PMID: 37571313 Free PMC article. Review.
-
The microbiome landscape in pediatric Crohn's disease and therapeutic implications.Gut Microbes. 2023 Dec;15(2):2247019. doi: 10.1080/19490976.2023.2247019. Gut Microbes. 2023. PMID: 37614093 Free PMC article. Review.
-
Effects of kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats.Heliyon. 2022 Dec 29;9(1):e12707. doi: 10.1016/j.heliyon.2022.e12707. eCollection 2023 Jan. Heliyon. 2022. PMID: 36685418 Free PMC article.
References
-
- Baldin R, Telles J, Bonardi R, Amarante H, Baldin Júnior A. Do standardization and quantification of histopathological criteria improve the diagnosis of inflammatory bowel disease? J. Bras. Patol. Med. Lab. 2014; 50: 221–8. 10.5935/1676-2444.20140019. - DOI
-
- Seksik P. Gut microbiota and IBD. Gastroenterol. Clin. Biol. 2010; 34(Suppl. 1): S44–51. - PubMed
-
- Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunol. Rev. 2005; 206: 277–95. - PubMed
LinkOut - more resources
Full Text Sources